Cargando…

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining

In colorectal cancer, tumor budding is associated with tumor progression and represents an additional prognostic factor in the TNM classification. Tumor buds can be found at the invasive front (peritumoral budding; PTB) and in the tumor center (intratumoral budding; ITB) of primary tumors. Previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Blank, Annika, Schenker, Carla, Dawson, Heather, Beldi, Guido, Zlobec, Inti, Lugli, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834648/
https://www.ncbi.nlm.nih.gov/pubmed/31737639
http://dx.doi.org/10.3389/fmed.2019.00247
_version_ 1783466519668195328
author Blank, Annika
Schenker, Carla
Dawson, Heather
Beldi, Guido
Zlobec, Inti
Lugli, Alessandro
author_facet Blank, Annika
Schenker, Carla
Dawson, Heather
Beldi, Guido
Zlobec, Inti
Lugli, Alessandro
author_sort Blank, Annika
collection PubMed
description In colorectal cancer, tumor budding is associated with tumor progression and represents an additional prognostic factor in the TNM classification. Tumor buds can be found at the invasive front (peritumoral budding; PTB) and in the tumor center (intratumoral budding; ITB) of primary tumors. Previous studies have shown that tumor buds are also present in colorectal liver metastases (CRLM). Data on the prognostic and predictive role in this clinical context are still sparse and no standardized approach to evaluate budding in CRLM has been published so far. This study aimed to analyze and correlate perimetastatic (PMB) and intrametastatic budding (IMB) on H&E and pancytokeratin staining, compare it to budding results in corresponding primary tumors and to propose a standardized scoring system in CRLM as the basis for future studies. Tumor tissue of 81 primary tumors and 139 corresponding CRLM was used for ngTMA construction. For each primary tumor and metastasis, two punches from the center and two punches from the periphery from areas with highest tumor budding density were included. TMA slides were stained for H&E and pancytokeratin (Pan-CK). PTB, ITB, PMB, and IMB were analyzed and classified as bd1, bd2, and bd3 according to ITBCC guidelines. ITB and PTB as well as IMB and PMB showed significant correlation on H&E and Pan-CK staining. No correlation was found for tumor bud counts in primary tumors and corresponding metastases. The agreement for categorized tumor bud counts showed fair to good agreement for metastases and poor agreement for primary tumors between different classes on H&E and Pan-CK staining. Based on our results, tumor budding in primary tumors and CRLM seems to be different processes which might be the results of differing surrounding microenvironments. The evaluation of tumor budding in CRLM is challenging in cases without desmoplastic stroma reaction or intense perimetastatic ductular reaction. We therefore propose to evaluate tumor budding only in metastases with desmoplastic stroma reaction based on H&E staining since important morphological features are obscured on Pan-CK staining.
format Online
Article
Text
id pubmed-6834648
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68346482019-11-15 Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining Blank, Annika Schenker, Carla Dawson, Heather Beldi, Guido Zlobec, Inti Lugli, Alessandro Front Med (Lausanne) Medicine In colorectal cancer, tumor budding is associated with tumor progression and represents an additional prognostic factor in the TNM classification. Tumor buds can be found at the invasive front (peritumoral budding; PTB) and in the tumor center (intratumoral budding; ITB) of primary tumors. Previous studies have shown that tumor buds are also present in colorectal liver metastases (CRLM). Data on the prognostic and predictive role in this clinical context are still sparse and no standardized approach to evaluate budding in CRLM has been published so far. This study aimed to analyze and correlate perimetastatic (PMB) and intrametastatic budding (IMB) on H&E and pancytokeratin staining, compare it to budding results in corresponding primary tumors and to propose a standardized scoring system in CRLM as the basis for future studies. Tumor tissue of 81 primary tumors and 139 corresponding CRLM was used for ngTMA construction. For each primary tumor and metastasis, two punches from the center and two punches from the periphery from areas with highest tumor budding density were included. TMA slides were stained for H&E and pancytokeratin (Pan-CK). PTB, ITB, PMB, and IMB were analyzed and classified as bd1, bd2, and bd3 according to ITBCC guidelines. ITB and PTB as well as IMB and PMB showed significant correlation on H&E and Pan-CK staining. No correlation was found for tumor bud counts in primary tumors and corresponding metastases. The agreement for categorized tumor bud counts showed fair to good agreement for metastases and poor agreement for primary tumors between different classes on H&E and Pan-CK staining. Based on our results, tumor budding in primary tumors and CRLM seems to be different processes which might be the results of differing surrounding microenvironments. The evaluation of tumor budding in CRLM is challenging in cases without desmoplastic stroma reaction or intense perimetastatic ductular reaction. We therefore propose to evaluate tumor budding only in metastases with desmoplastic stroma reaction based on H&E staining since important morphological features are obscured on Pan-CK staining. Frontiers Media S.A. 2019-10-31 /pmc/articles/PMC6834648/ /pubmed/31737639 http://dx.doi.org/10.3389/fmed.2019.00247 Text en Copyright © 2019 Blank, Schenker, Dawson, Beldi, Zlobec and Lugli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Blank, Annika
Schenker, Carla
Dawson, Heather
Beldi, Guido
Zlobec, Inti
Lugli, Alessandro
Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
title Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
title_full Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
title_fullStr Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
title_full_unstemmed Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
title_short Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
title_sort evaluation of tumor budding in primary colorectal cancer and corresponding liver metastases based on h&e and pancytokeratin staining
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834648/
https://www.ncbi.nlm.nih.gov/pubmed/31737639
http://dx.doi.org/10.3389/fmed.2019.00247
work_keys_str_mv AT blankannika evaluationoftumorbuddinginprimarycolorectalcancerandcorrespondinglivermetastasesbasedonheandpancytokeratinstaining
AT schenkercarla evaluationoftumorbuddinginprimarycolorectalcancerandcorrespondinglivermetastasesbasedonheandpancytokeratinstaining
AT dawsonheather evaluationoftumorbuddinginprimarycolorectalcancerandcorrespondinglivermetastasesbasedonheandpancytokeratinstaining
AT beldiguido evaluationoftumorbuddinginprimarycolorectalcancerandcorrespondinglivermetastasesbasedonheandpancytokeratinstaining
AT zlobecinti evaluationoftumorbuddinginprimarycolorectalcancerandcorrespondinglivermetastasesbasedonheandpancytokeratinstaining
AT luglialessandro evaluationoftumorbuddinginprimarycolorectalcancerandcorrespondinglivermetastasesbasedonheandpancytokeratinstaining